BIOSPECIFICS TECHNOLOGIES CORP Debt Securities, Held-to-maturity
BIOSPECIFICS TECHNOLOGIES CORP had Debt Securities, Held-to-maturity of $63.60 million as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Assets
us-gaap:HeldToMaturitySecurities · last filed 2018-11-09
- 2018-09-30: Debt Securities, Held-to-maturity $63.60M.
- 2018-06-30: Debt Securities, Held-to-maturity $60.70M.
- 2018-03-31: Debt Securities, Held-to-maturity $51.60M.
- 2017-12-31: Debt Securities, Held-to-maturity $57.70M.
| Period end | Debt Securities, Held-to-maturity |
|---|---|
| 2018-09-30 | $63.60M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $60.70M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $51.60M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $57.70M 10-Q · filed 2018-11-09 |
| 2015-09-30 | $25.30M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $20.70M 10-Q · filed 2015-08-10 |
| 2014-12-31 | $12.20M 10-Q · filed 2015-11-09 |